Cancer cells are continuously challenged by a limited oxygen, nutrients supply, and elevated protein synthesis. All these circumstances induce ER stress and Unfolded Protein Response (UPR). A huge amount of evidence demonstrates that the UPR is a crucial process for cancer cells to keep malignancy but also that, prolonged pharmacological induction of UPR, can be effective for promoting cancer cell death. Here we show that inhibition of the Hexosamine Biosynthetic Pathway (HBP) by means of a specific HBP inhibitor, FR054, causes a prolonged activation of the UPR that induces, in breast cancer (BC) cells, ROS accumulation and cell death. Conversely, such a ROS-dependent mechanism is somewhat inhibited in pancreatic cancer (PC) cells. However parallel inhibition of xCT/SLC7A11, involved in glutathione biosynthesis, by erastin (ERA), a recognized ferroptosis inducer, significantly enhanced the FR054 effect causing a noteworthy increase in cancer cell proliferation arrest and death.

Zerbato, B., Brancato, V., Gobbi, M., Pessina, A., Brambilla, L., Wegner, A., et al. (2024). Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy. Intervento presentato a: FEBS YSF 2024, Pavia, Italy.

Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy

Zerbato, B
Primo
;
Brancato, V
Secondo
;
Gobbi, M;Chiaradonna, F.
Ultimo
2024

Abstract

Cancer cells are continuously challenged by a limited oxygen, nutrients supply, and elevated protein synthesis. All these circumstances induce ER stress and Unfolded Protein Response (UPR). A huge amount of evidence demonstrates that the UPR is a crucial process for cancer cells to keep malignancy but also that, prolonged pharmacological induction of UPR, can be effective for promoting cancer cell death. Here we show that inhibition of the Hexosamine Biosynthetic Pathway (HBP) by means of a specific HBP inhibitor, FR054, causes a prolonged activation of the UPR that induces, in breast cancer (BC) cells, ROS accumulation and cell death. Conversely, such a ROS-dependent mechanism is somewhat inhibited in pancreatic cancer (PC) cells. However parallel inhibition of xCT/SLC7A11, involved in glutathione biosynthesis, by erastin (ERA), a recognized ferroptosis inducer, significantly enhanced the FR054 effect causing a noteworthy increase in cancer cell proliferation arrest and death.
abstract + poster
Pancreatic cancer, UPR, ER stress, Hexosamine Biosynthetic Pathway
English
FEBS YSF 2024
2024
2024
open
Zerbato, B., Brancato, V., Gobbi, M., Pessina, A., Brambilla, L., Wegner, A., et al. (2024). Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy. Intervento presentato a: FEBS YSF 2024, Pavia, Italy.
File in questo prodotto:
File Dimensione Formato  
Zerbato-2024-FEBS YSF 2024-preprint.pdf

accesso aperto

Descrizione: Intervento a convegno - abstract
Tipologia di allegato: Submitted Version (Pre-print)
Licenza: Altro
Dimensione 118.83 kB
Formato Adobe PDF
118.83 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/499139
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact